Johnson & Johnson has only a few million COVID-19 vaccine doses in stock as likely launch nears
By Carl O'Donnell and Jarrett Renshaw (Reuters) - Johnson & Johnson has only a few million doses of its experimental COVID-19 vaccine in its inventory even as likely U.S. regulatory authorization is only a few weeks away, White House officials said on Wednesday. J&J remains committed to providing 100 million doses by June but deliveries are likely to be 'back-end loaded' as J&J works with the U.S.
COVID-19 vaccine doses in stock as likely launch nears" src="https://images.firstpost.com/wp-content/uploads/reuters/02-2021/18/2021-02-17T173308Z_1_LYNXMPEH1G1GD_RTROPTP_2_HEALTH-CORONAVIRUS-INDIA-JOHNSON-JOHNSON.jpg" alt="Johnson amp Johnson has only a few million COVID19 vaccine doses in stock as likely launch nears" width="300" height="225" />
By Carl O'Donnell and Jarrett Renshaw
(Reuters) - Johnson & Johnson has only a few million doses of its experimental COVID-19 vaccine in its inventory even as likely U.S. regulatory authorization is only a few weeks away, White House officials said on Wednesday.
J&J remains committed to providing 100 million doses by June but deliveries are likely to be "back-end loaded" as J&J works with the U.S. government to boost supply, said Jeffrey Zients, the White House's COVID-19 response coordinator, on a press call. “Across the last few weeks we've learned that there is not a big inventory of Johnson and Johnson. There's a few million doses that we’ll start with," Zients said.
The United States has been struggling to hasten its vaccine rollout because of a limited supply of doses. Pfizer Inc and Moderna Inc have promised to deliver 200 million doses of their two-dose vaccines by the end of March but so far fewer than 72 million doses have been shipped around the U.S. and around 55 million shots have been given.
J&J's experimental shot involves a single dose and can be stored in refrigerators as opposed to freezers, which could help speed up vaccinations.
Zients said the vaccine could be authorized in a couple of weeks. It is scheduled to be reviewed on Feb. 26 by a panel of outside advisors to the U.S. Food and Drug Administration.
(Reporting by Carl O'Donnell; Editing by Chris Reese)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply
By Christoph Steitz, Tom Käckenhoff and Arno Schuetze FRANKFURT (Reuters) - German conglomerate Thyssenkrupp ended talks to sell its steel division to Britain's Liberty Steel due to differences over value, the latest setback in efforts to consolidate the European sector. Liberty Steel, led by commodities tycoon Sanjeev Gupta, last month submitted a firmed-up non-binding bid for Thyssenkrupp's steel unit, Europe's second biggest in terms of sales, which sources said included commitments to protect jobs and sites.
(Reuters) - Reddit trading lingo may filter in to Washington on Thursday when top hedge fund managers, the head of Robinhood and Roaring Kitty himself are set to give testimony before U.S. House of Representatives lawmakers.
By Stephanie Kelly NEW YORK (Reuters) - Oil prices steadied on Thursday, with Brent edging back from a 13-month high, after a sharp drop in U.S. crude inventories supported prices, while buying spurred by a cold snap in the largest U.S. energy-producing state petered out.